학술논문

ePHex: a phase 3, double-blind, placebo-controlled, randomized study to evaluate long-term efficacy and safety of Oxalobacter formigenes in patients with primary hyperoxaluria
Document Type
Article
Source
In: Pediatric Nephrology. (Pediatric Nephrology, February 2023, 38(2):403-415)
Subject
Language
English
ISSN
1432198X
0931041X